Current position

Ray Dalio’s Ovintiv Inc (OVV) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Bridgewater Associates, LPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ1 2020Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares1.24MHighest verified quarter-end share count
Quarters reported21Verified quarters with shares above zero
What happened?

Bridgewater Associates, LP first reported Ovintiv Inc in Q1 2020. After an earlier exit, the position later appeared again in a verified filing. The reported position was increased and reduced across later filings. Bridgewater Associates, LP currently reports 1.04M shares. The latest verified filing showed: Bought 181.5% more.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Bought 181.5% more+671.35K shares · 1.04M shares reported after the change
Filing context

Quarter-end price $52.65 · Estimated holding basis $48.58

Q1 2026
Sold 70.2% of the position−869.65K shares · 369.97K shares remained
Filing context

Quarter-end price $59.36 · Estimated holding basis $41.19

Q4 2025
Bought 11.4% more+126.85K shares · 1.24M shares reported after the change
Filing context

Quarter-end price $39.19 · Estimated holding basis $41.19

Q3 2025
Bought 50.1% more+371.34K shares · 1.11M shares reported after the change
Filing context

Quarter-end price $40.38 · Estimated holding basis $41.42

Q2 2025
Bought 51.9% more+253.31K shares · 741.42K shares reported after the change
Filing context

Quarter-end price $38.05 · Estimated holding basis $41.94

Q1 2025
Bought 67.4% more+196.47K shares · 488.11K shares reported after the change
Filing context

Quarter-end price $42.80 · Estimated holding basis $43.96

1 unchanged quarter is collapsed by default.

Portfolio importance

How important is Ovintiv Inc in Bridgewater Associates, LP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.2%Q2 2026
Current rank#69of 997 reported positions
Peak portfolio weight0.2%Q2 2026
Best historical rank#69Q2 2026
At peak importanceQ2 2026
OVV
0.2%
Largest holding
16.3%
Cross-investor discovery

Who else owns Ovintiv Inc?

Also reported by 1 other tracked investor in their latest verified filings.

Joel GreenblattGotham Asset Management
OVV0.0% of reported portfolio
Explore Ovintiv Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$63.692026-09-11

Market context only; not an investor transaction price.

Latest filing quarter-end price$52.65Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$48.58Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Bridgewater Associates, LP’s Form 13F disclosures, not Ray Dalio’s personal brokerage account. Form 13F reports quarter-end positions later and does not reveal exact trade dates or execution prices.